DOCSLIB.ORG

Vascular Surgery a Comprehensive Illustrated Guide to Coding and Reimbursement

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vascular Surgery a Comprehensive Illustrated Guide to Coding and Reimbursement ATCR.book Page 1 Tuesday, November 20, 2012 3:07 PM Coding Companion for Cardiology/Cardiothoracic/ Vascular Surgery A comprehensive illustrated guide to coding and reimbursement 2015 ATCR.book Page i Tuesday, November 20, 2012 3:07 PM Contents Getting Started with Coding Companion .............................i Diaphragm ......................................................................586 Chest Wall ...........................................................................1 Esophagus .......................................................................589 General Musculoskeletal ......................................................2 Abdomen ........................................................................635 Neck and Thorax .................................................................4 Thyroid Gland .................................................................640 Larynx ...............................................................................24 Parathyroid......................................................................641 Trachea and Bronchi ..........................................................28 Nervous System...............................................................644 Lungs and Pleura ...............................................................56 Medicine .........................................................................651 Heart and Pericardium .....................................................129 Appendix.........................................................................718 Arteries and Veins ............................................................293 Evaluation and Management ...........................................775 Lymph Nodes ..................................................................579 Index...............................................................................795 Mediastinum ...................................................................582 CPT © 2013 American Medical Association. All Rights Reserved. © 2014 OptumInsight, Inc. Coding Companion for Cardiology/Cardiothoracic/Vascular Surgery Contents reported separately. Any additional repair or hypertension first: 402.0-402.9, with 33945 resection procedures on the donor heart are fifth-digit 1 or 404.0-404.9 with fifth 33945 Heart transplant, with or without recipient also reported separately, see 33300, 33310, digit 1 or 3) 33320, 33400, 33463, 33464, 33510, 33641, cardiectomy 428.22 Chronic systolic heart failure — (Code, 35216, 35276, or 35685. Donor cardiectomy and any backbench work, repair, or resection if applicable, heart failure due to procedures on the donor heart are usually the hypertension first: 402.0-402.9, with financial responsibility of the recipient. fifth-digit 1 or 404.0-404.9 with fifth digit 1 or 3) ICD-9-CM Procedural 428.32 Chronic diastolic heart failure — 00.93 Transplant from cadaver (Code, if applicable, heart failure due 37.51 Heart transplantation to hypertension first: 402.0-402.9, with fifth-digit 1 or 404.0-404.9 with 39.61 Extracorporeal circulation auxiliary to fifth digit 1 or 3) open heart surgery 428.42 Chronic combined systolic and Anesthesia diastolic heart failure — (Code, if 33945 00580 applicable, heart failure due to hypertension first: 402.0-402.9, with ICD-9-CM Diagnostic fifth-digit 1 or 404.0-404.9 with fifth 398.0 Rheumatic myocarditis digit 1 or 3) 412 Old myocardial infarction — (Use 429.0 Unspecified myocarditis — (Use additional code to identify presence additional code to identify presence of hypertension: 401.0-405.9) of arteriosclerosis) 414.00 Coronary atherosclerosis of 429.1 Myocardial degeneration — (Use unspecified type of vessel, native or additional code to identify presence graft — (Use additional code to of arteriosclerosis) identify presence of hypertension: 429.2 Unspecified cardiovascular disease — Heart and Pericardium Explanation 401.0-405.9) (Use additional code to identify The patient is placed on cardiopulmonary 414.01 Coronary atherosclerosis of native presence of arteriosclerosis) bypass. Cardiac transplantation may be coronary artery — (Use additional 746.9 Unspecified congenital anomaly of performed by one of two techniques: total code to identify presence of heart orthotopic heart replacement or heterotropic hypertension: 401.0-405.9) implantation. A total orthotopic heart 414.02 Coronary atherosclerosis of CCI Version 18.3 replacement involves excising the ventricles, 0213T, 0216T, 0228T, 0230T, 12001-12007, autologous vein bypass graft — (Use atrial appendages, and most of the coronary 12011-12057, 13100-13153, 32100, 32422, additional code to identify presence sinus from the donor heart. The recipient heart 32551, 33210-33211, 33310-33315, 35226, is then opened. The atria, aorta, and of hypertension: 401.0-405.9) 36000, 36400-36410, 36420-36430, 36440, pulmonary artery of the recipient heart are 414.04 Coronary atherosclerosis of artery 36600, 36640, 37202, 39000-39010, 43752, anastomosed to the donor heart. The sinoatrial bypass graft — (Use additional code 51701-51703, 62310-62319, 64400-64435, nodes of both the donor and recipient heart to identify presence of hypertension: 64445-64450, 64479, 64483, 64490, 64493, are left intact. In a heterotropic implantation, 401.0-405.9) 64505-64530, 69990, 93000-93010, the donor's organs are placed by sewing the 93040-93042, 93318, 94002, 94200, 94250, 414.8 Other specified forms of chronic left atrium of the donor heart to the left atrium 94680-94690, 94770, 95812-95816, 95819, ischemic heart disease — (Use of the recipient, and then sewing together the 95822, 95829, 95955, 96360, 96365, 96372, atrial septums and the right atrium. The donor additional code to identify presence 96374-96376, 99148-99149, 99150 of hypertension: 401.0-405.9) aorta is then trimmed to an appropriate length Note: These CCI edits are used for Medicare. and sewn to the ascending aorta of the 422.91 Idiopathic myocarditis Other payers may reimburse on codes listed recipient. Immunosuppressive drugs may be 422.92 Septic myocarditis — (Use additional above. given to the patient before, during, and after code to identify infectious organism) the operation. Cardiopulmonary bypass is Medicare Edits discontinued when the donor heart begins 422.93 Toxic myocarditis Fac Non-Fac functioning in the recipient. 425.0 Endomyocardial fibrosis RVU RVU FUD Status 425.3 Coding Tips Endocardial fibroelastosis 33945 145.58 145.58 R90 425.4 Other primary cardiomyopathies Heart transplantation involves three distinct MUE Modifiers 428.0 Congestive heart failure, unspecified components. Code 33945 includes only 33945 8062*N/A511 transplant of the cadaver donor heart with or — (Code, if applicable, heart failure * with documentation without recipient cardiectomy and care of the due to hypertension first: Medicare References: 100-2,15,50.5; recipient. Cadaver cardiectomy (33940) is 402.0-402.9, with fifth-digit 1 or 100-2,15,60.3; 100-3,260.9; 100-4,3,90.2.1 reported separately. Backbench work (33944), 404.0-404.9 with fifth digit 1 or 3) which involves preparation of the cadaver 428.1 Left heart failure — (Code, if donor heart allograft prior to transplant, is also applicable, heart failure due to CPT © 2013 American Medical Association. All Rights Reserved. © 2014 OptumInsight, Inc. Coding Companion for Cardiology/Cardiothoracic Surgery/Vascular Surgery Heart and Pericardium — 279 Explanation Explanation 36400 A needle is inserted through the skin to puncture a The physician performs a push transfusion on a child 36400 Venipuncture, younger than age 3 years, vein of a person 3 years of age or older. The needle 2 years old and under. The physician calculates the necessitating the skill of a physician or is inserted into the vein and used for the withdrawal amount of blood to be transfused and slowly injects other qualified health care professional, of blood for diagnostic study or for the therapeutic it into the patient using a needle or existing infusion of intravenous medication. A soft flexible catheter. not to be used for routine venipuncture; catheter may be placed for prolonged therapy. Once femoral or jugular vein the procedure is complete, the needle or catheter 36450-36455 is withdrawn and pressure is applied over the 36450 Exchange transfusion, blood; newborn Explanation puncture site to control bleeding. Use this code 36455 other than newborn A needle is inserted through the skin to puncture when the venipuncture necessitates the skills of a the femoral or jugular vein of a child younger than physician or other qualified health care professional. age 3. The needle is inserted into the vein and used Do not use this code when routine venipuncture is Explanation for the withdrawal of blood for diagnostic study or performed. The physician performs an exchange transfusion on for the therapeutic infusion of intravenous a newborn. The physician calculates the blood medication. A soft flexible catheter may be placed Coding Tips volume to be transfused. A needle is placed in an for prolonged therapy. Once the procedure is This code has been revised for 2013 in the official artery or in an existing arterial catheter. The patient's complete, the needle or catheter is withdrawn and CPT description. blood is removed and replaced simultaneously to pressure is applied over the puncture site to control maintain blood pressure. Report 36455 if the child bleeding. Use this code for venipuncture when it is other than a newborn. necessitates the skill of a physician or other qualified 36415-36416 health
Load more

Recommended publications
  • The Incidence of Microemboli to the Brain Is Less with Endarterectomy Than with Percutaneous Revascularization with Distal filters Or flow Reversal
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector From the Southern Association for Vascular Surgery The incidence of microemboli to the brain is less with endarterectomy than with percutaneous revascularization with distal filters or flow reversal Naren Gupta, MD, PhD,a Matthew A. Corriere, MD, MS,a,c Thomas F. Dodson, MD,a Elliot L. Chaikof, MD, PhD,a Robert J. Beaulieu, BS,b James G. Reeves, MD,a Atef A. Salam, MD,a and Karthikeshwar Kasirajan, MD,a Atlanta, Ga Background: Current data suggest microembolization to the brain may result in long-term cognitive dysfunction despite the absence of immediate clinically obvious cerebrovascular events. We reviewed a series of patients treated electively with carotid endarterectomy (CEA), carotid artery stenting (CAS) with distal filters, and carotid stenting with flow reversal (FRS) monitored continuously with transcranial Doppler scan (TCD) during the procedure to detect microembolization rates. Methods: TCD insonation of the M1 segment of the middle cerebral artery was conducted during 42 procedures (15 CEA, 20 CAS, and 7 FRS) in 41 patients seen at an academic center. One patient had staged bilateral CEA. Ipsilateral microembolic signals (MESs) were divided into three phases: preprotection phase (until internal carotid artery [ICA] cross-shunted or clamped if no shunt was used, filter deployed, or flow reversal established), protection phase (until clamp/shunt was removed, filter removed, or antegrade flow re-established), and postprotection phase (after clamp/ shunt was removed, filter removed, or antegrade flow re-established). Descriptive statistics are reported as mean ؎ SE for continuous variables and N (%) for categorical variables.
    [Show full text]
  • Research Article Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation International Journal of Vascular Medicine Volume 2016, Article ID 3805380, 6 pages http://dx.doi.org/10.1155/2016/3805380 Research Article Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry Kimihiro Igari, Toshifumi Kudo, Takahiro Toyofuku, and Yoshinori Inoue Division of Vascular and Endovascular Surgery, Department of Surgery, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan Correspondence should be addressed to Kimihiro Igari; [email protected] Received 16 July 2016; Revised 17 September 2016; Accepted 27 September 2016 Academic Editor: Thomas Schmitz-Rixen Copyright © 2016 Kimihiro Igari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. Endothelial dysfunction plays a key role in atherosclerotic disease. Several methods have been reported to be useful for evaluating the endothelial dysfunction, and we investigated the endothelial dysfunction in patients with peripheral arterial disease (PAD) using peripheral arterial tonometry (PAT) test in this study. Furthermore, we examined the factors significantly correlated with PAT test. Methods. We performed PAT tests in 67 patients with PAD. In addition, we recorded the patients’ demographics, including comorbidities, and hemodynamical status, such as ankle brachial pressure index (ABI). Results. In a univariate analysis, the ABI value ( = 0.271, = 0.029) and a history of cerebrovascular disease ( = 0.208, = 0.143) were found to significantly correlatewithPATtest,whichcalculatedthereactivehyperemiaindex(RHI).Inamultivariateanalysis,onlytheABIvalue significantly and independently correlated with RHI ( = 0.254, = 0.041).
    [Show full text]
  • New York State Surgical and Invasive Procedure Protocol (NYSSIPP)
    State of New York Department of Health Office of Health Systems Management Division of Primary and Acute Care Services New York State Surgical and Invasive Procedure Protocol for Hospitals ~ Diagnostic and Treatment Centers Ambulatory Surgery Centers ~ Individual Practitioners Antonia C. Novello, M.D., M.P.H., Dr.P.H. Commissioner of Health Hon. George E. Pataki Governor – State of New York September 2006 Surgical and Invasive Procedure Protocol September 2006 NEW YORK STATE SURGICAL AND INVASIVE PROCEDURE PROTOCOL (FOR THE PREVENTION OF WRONG PATIENT, WRONG SITE, WRONG SIDE & WRONG INVASIVE PROCEDURE EVENTS) I. STATEMENT OF PURPOSE The State of New York is committed to providing its residents access to quality health care. Hon. George E. Pataki, Governor and Antonia C. Novello M.D., M.P.H., Dr.P.H., Commissioner of Health, continue to work toward a system that reduces medical and surgical errors by commitment to a safe and protected patient care environment. Key to achieving this goal is promoting a culture of safety and strengthening open communication among health care providers, individual practitioners and the patients they serve. One of the goals of Governor Pataki and Commissioner Novello, is the elimination of wrong patient, wrong site, wrong side and wrong invasive procedures, through the development of comprehensive systems that ensure the correct procedure is done on the correct patient on the correct site. Increased practitioner awareness combined with strong provider protocols and standardization will enhance the patient safety measures currently in place. The New York State Surgical and Invasive Procedure Protocol (NYSSIPP) developed by the Procedural and Surgical Site Verification Panel (PSSVP) is intended for all patient care settings and for all individual practitioners.
    [Show full text]
  • Fluorescein Angiography: Preventing and Responding to Complications
    Fluorescein Angiography: Preventing and Responding to Complications Jacqueline G. Jaffee, J.D. OMIC Risk Management Specialist PURPOSE OF RISK MANAGEMENT RECOMMENDATIONS OMIC regularly analyzes its claims experience to determine loss prevention measures that our insured ophthalmologists can take to reduce the likelihood of professional liability lawsuits. OMIC policyholders are not required to implement these risk management recommendations. Use your professional judgment in determining the applicability of a given recommendation to their particular patients and practice situation. These loss prevention documents may refer to clinical care guidelines such as the American Academy of Ophthalmology’s Preferred Practice Patterns, peer-reviewed articles, or to federal or state laws and regulations. However, our risk management recommendations do not constitute the standard of care nor do they provide legal advice. If legal advice is desired or needed, consult an attorney. Information contained here is not intended to be a modification of the terms and conditions of the OMIC professional and limited office premises liability insurance policy. Please refer to the OMIC policy for these terms and conditions. Version 1/24/08 Fluorescein angiography (FA) is a diagnostic procedure in which a rapid sequence of photographs is taken to document the blood circulation of the retina/choroid. The dye is usually injected into a vein in the arm, forearm, or hand. While generally well tolerated, angiography is an invasive procedure with associated risks, very rarely but notably of a life-threatening allergic reaction. The following risk management recommendations have been compiled to assist you and your staff so that you may both prevent and better respond to the risks of the procedure.
    [Show full text]
  • Anti-Apolipoprotein A-1 Igg Influences Neutrophil Extracellular Trap
    International Journal of Molecular Sciences Article Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques Rafaela F. da Silva 1,2 , Daniela Baptista 1, Aline Roth 1, Kapka Miteva 1 , Fabienne Burger 1, Nicolas Vuilleumier 3,4, Federico Carbone 5,6 , Fabrizio Montecucco 5,6 , François Mach 1 and Karim J. Brandt 1,* 1 Division of Cardiology, Foundation for Medical Researches, Department of Medicine Specialties, Faculty of Medicine, University of Geneva, Av. de la Roseraie 64, 1211 Geneva, Switzerland; [email protected] (R.F.d.S.); [email protected] (D.B.); [email protected] (A.R.); [email protected] (K.M.); [email protected] (F.B.); [email protected] (F.M.) 2 Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-901 Belo Horizonte, Brazil 3 Department of Diagnostics, Division of Laboratory Medicine, Geneva University Hospitals, 1211 Geneva, Switzerland; [email protected] 4 Department of Medical Specialities, Division of Laboratory Medicine, Faculty of Medicine, 1211 Geneva, Switzerland 5 First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, viale Benedetto XV n6, 16132 Genoa, Italy; [email protected] (F.C.); [email protected] (F.M.) 6 IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network, Largo Rosanna Benzi n10, 16132 Genoa, Italy * Correspondence: [email protected]; Tel.: +41-2237-94-647 Received: 9 September 2020; Accepted: 13 October 2020; Published: 19 October 2020 Abstract: Background: Neutrophils accumulate in atherosclerotic plaques. Neutrophil extracellular traps (NET) were recently identified in experimental atherosclerosis and in complex human lesions.
    [Show full text]
  • The Cardiopulmonary Bypass, Hemolysis, and End Organ Function: an Integration of Political Science, Chemistry, and Zoology
    The Cardiopulmonary Bypass, Hemolysis, and end organ function: an Integration of Political Science, Chemistry, and Zoology By Nathan V. Luce A capstone project submitted to the faculty of Weber State University in fulfillment of the requirements of the degree of Bachelor of Integrated Studies in the Department of Integrated Studies. Ogden, Utah (Date Approved) Approved by: Department Director Dr. Michael Cena Ph.D. Committee Members: Political Science Dr. Gary Johnson Ph.D. Clinical and Clinical Research: Chemistry and Zoology Dr. Peter C. Minneci M.D. Marie Hart Clayton MSN, RN TABLE OF CONTENTS PREFACE......................................................................................................................................... v INTRODUCTION............................................................................................................................... 1 HISTORY AND BASICS: CARDIAC SURGERY AND THE CPB.................................................... 3 Evolution of Cardiac Surgery............................................................................................ 3 Intraoperative........................................................................................................... 5 Effects of Cardiopulmonary Bypass................................................................................. 6 Mechanical............................................................................................................... 6 Physiological: Whole Body Inflammatory Response...............................................
    [Show full text]
  • Cervical Epidural Anaesthesia for Carotid Artery Surgery
    353 Cervical epidural Francis Bonnet MD,* Jean Paul Derosier MD,'i" anaesthesia for carotid Frederic Pluskwa MD,* Kou Abhay MD,* A. Gaillard MDt artery surgery A series of 394 patients (251 men, 143 women; mean age 70.0 +- C2 d D4-D8 a ainsi dtd obtenu. Les patients sont restds dveillds 8.4 yr) selected for carotid artery" surgery, (CAS) performed pendant la durde de l'acte opdratoire dans des conditions de under cervical epidural anaesthesia (CEA ) was analysed retro- confort acceptables. Les complications sdrieuses rencontrdes spectively. Carotid endarterectomy was performed in 326 ont dtd la survenue d'une brdche duremdrienne dans deux cas, patients and saphenous vein bypass in 68. The cervical epidural d'une brdche vasculaire dans six cas et d'une insuffisance administration of 15 ml 0.5 per cent bupivacaine or 0.37-0.40 respiratoire chez trois patients. Hypotension (10,9 pour cent et per cent bupivacaine plus fentanyl (50-100 Izg) resulted in an bradycardie (2,8 pour cent) dtaient les effets secondaires les effective sensory blockade from C2 to T4-Ts. Patients were plus frdquemment observds. Un accident neurologique transi- maintained awake during the surgical procedure in comfortable toire s'est produit chez 84 patients pendant I'intervention condition. Serious complications included dural puncture in two chirugicale. Un accident neurologique irrdversible est survenu patients, epidural venipuncture in six patients and respiratory chez 12 patients. Trois infarctus du myocarde ont dtE diagnos- muscle paralysis in three patients. Hypotension (10.9 per cent) tiquds dans les suites opdratoires. La mortalitE de cette sdrie and bradycardia (2.8 per cent) were the most frequent side- Eta# de 2,3 pour cent.
    [Show full text]
  • Reviewing Approaches to Blood Draws
    Reviewing Approaches to Blood Draws Pitou Devgon, MD 700-0015 Rev A © 2018 Introduction & Disclosures Pitou Devgon,MD,MBA • Chief Medical Officer, Co-Founder & PIVO Inventor • MICU Hospitalist Physician, Philadelphia VA Medical Center • Association of Vascular Access (AVA) Foundation Board Member * Employee, shareholder and board member of Velano Vascular, Inc. © 2018 Tonight’s Agenda 1. Suboptimal Blood Collection Practices 2. Hurdles of PIV Blood Aspiration 3. Vascular Anatomy and the Role in Access © 2018 A Ubiquitous Yet Suboptimal Procedure 1.6 – 2.2X Average daily draws 28% Adults, 43% Peds > 1 stick attempt ~450M 15-25% CONDUCTED EVERY YEAR 88% Nurses 3+ Draws Daily IN U.S. HOSPITALS (INPATIENT) Say sticks / re-sticks impact patient experience © 2018 * Internal Data on File Venous Depletion: Setting the Stage • Definition Attempt: Loss of suitable veins for cannulation, IV therapy or dialysis due to damage from existing or past VADs or venipuncture • Venous depletion, vein wasting and vein preservation are concepts gaining attention as a means to increase appropriate use of peripheral veins and reduce the need for central vascular access devices (CVADs) • Lynn Hadaway. Infusion Teams in Acute Care Hospitals. JIN. 2013 • Last few decades frequency & intensity of venous cannulations & venipunctures for hospitalized patients increased dramatically Category Volume Driving Factors: • PVD PIV 310,000,000 • • Previous vein injury Limitations on limbs by mastectomy, stroke or contractures CVC 5,000,000 • Phlebitis • Blood clots • Infiltrations • Hematomas • Hx of IV drug use PICC 2,000,000 • Use of certain medications • Prolonged bedrest (pH low/high) • Major surgery Midline ~400,000 • Hx of multiple venous • Obesity • Smoking Venipuncture ~400,000,000 cannulations • Some Cancers (Inpatient) © 2018 Pervasive Cannulations of Vessels Vascular Access Devices (VADs) are Ubiquitous DVA Population .
    [Show full text]
  • Vascular Access Devices
    VASCULAR ACCESS DEVICES Andrea Lemmo RN, BSN VA-BC Assistant Nurse Manager Vascular Access Team Sutter Medical Center Sacramento Vascular Access Practice Criteria Preserving venous access is essential Establishing and maintaining appropriate reliable access is vital Appropriate device selection and vascular access planning prevents intravenous related problems and complications for the patient Collaborative process among the inter-professional team Vascular Access Practice Standards Device Selection Collaborative process among the inter-professional team Accommodates the vascular access needs Prescribed therapy/treatment Duration of therapy Vascular characteristics Patient comorbidities Smallest diameter device, fewest lumens, least invasive 2 Types of Vascular Access Devices PERIPHERAL IV CENTRAL VENOUS ACCESS DEVICE Short catheters (less than 3 inches) Placed in IJ, subclavian, femoral Placed in the veins of the upper Long catheter whose tip extremities terminates in a great vessel Used for therapy less than 6 days in duration 3 Types of CVAD’s Contraindicated for use with Non-tunneled Continuous vesicants Tunneled Parenteral nutrition Implanted Infusates >900 mOsmL Midline Peripheral IV (PIV) Short catheters generally placed in forearm, hand, scalp vein and lower extremity Short term therapy (less than 6 days) when infusate is non-irritating Peripheral Sites Veins of the Forearm 1. Cephalic vein 2. Median Cubital vein 3. Accessory Cephalic vein 4. Basilic vein 5. Cephalic vein 6. Median antebrachial vein Peripheral
    [Show full text]
  • “Save the Veins” Vein Sparing for Patients with Renal Dysfunction
    “Save the Veins” Vein Sparing for patients with renal dysfunction A Did You Know? poster by Mary Sylvia-Reardon, RN, DNP Nursing Director of Hemodialysis Unit topic of intereSt PICC-certified members of the MGH IV Therapy Team related to the patient with renal insufficiency. The • The use of venous access devices requiring information gained from the responses identified placement in both central and peripheral veins has a need for education. This is a beginning step in become prevalent in modern medicine. the reduction of the number of PICCs placed in this • Peripherally inserted central catheters (PICCs) are patient population. IRB Protocol #:2009P000865; SRH vascular access devices that can be inserted through In discussions with the Nephrologists at MGH, there a peripheral vein with the tip terminating in the was evidence of hemodialysis patients having PICC central vascular system. placement that oftentimes could have been avoided. • Such catheters are inserted through an antecubital reView of literAture vein by needle puncture (Hertzog & Waybill, 2008). The literature revealed factors that contribute introDuction significantly to damage of upper extremity vessels: In many institutions, PICCs replace neck or chest • diameter, location and composition of the catheters wall central venous catheters as the access of choice • presence of disease processes for intermediate and long term intravenous therapy • infusion solutions (Gonsalves et al., 2003). Larger populations of patients receive these lines, not only for in-hospital • vein
    [Show full text]
  • Catheter Blood Collection Practices.Pdf
    Catheter Blood Collection Practices: Can A High Quality Sample for Laboratory Diagnostics be Obtained? Stephen Church Zorica Sumarac Expert Member Corresponding Member EFLM WG_PRE EFLM WG_PRE EFLM: E-learning Webinar Webinar Objectives • Why is IV Therapy Used? • Overview Types of Vascular Access Devices (VAD). • Current Guidelines • Nursing Prospective • Laboratory Prospective • Key Considerations • Recommendations • Questions throughout the webinar • Catheter, also known as cannula, cannulation • Focus of the webinar is IV catheters, no discussion on urinary catheters EFLM – E-learning Webinar Catheter Blood Collection Practices, 18 th September 2018 1 Why Intravenous Therapy? To restore and maintain fluid and electrolyte balance To administer medications: Anti-infective drugs Pain management Chemotherapy (antiviral/antibiotic) To infuse total parenteral nutrition (TPN) 'To administer a blood transfusion/blood products EFLM – E-learning Webinar Catheter Blood Collection Practices, 18 th September 2018 Why Vascular Access? Direct route to the bloodstream Rapid drug action Accurate and precise drug administration Drug therapy may be irritating or cannot be given via another route nutrition (TPN) Required for patients who cannot tolerate and/or absorb from the gastrointestinal tract EFLM – E-learning Webinar Catheter Blood Collection Practices, 18 th September 2018 2 Intravenous Therapy 350 Central role in patient care Years 60%–90% of patients receive IV therapy 1 One of the most common, yet complex invasive procedures 1.Helm RE, Klausner
    [Show full text]
  • 2008 Widener Dissertation
    DISEASE SEVERITY AND DISABILITY IN PERSONS WITH PERIPHERAL ARTERIAL DISEASE DISSERTATION Presented in Partial Fulfillment of the Requirements for The Degree of Doctor of Philosophy in the Graduate School of The Ohio State University By Jeanne Malcom Widener * * * * * The Ohio State University 2008 Dissertation Committee: Professor Pamela J. Salsberry, advisor Approved by: Professor Kathleen A. Stone Professor Barbara Polivka _________________________ Professor Linda K. Daley Advisor College of Nursing Copyright by Jeanne M. Widener 2008 ABSTRACT Peripheral arterial disease (PAD) is a serious condition that can lead to long-term disability. Recently the National Heart, Lung and Blood Institute began a campaign to educate the public and increase awareness of PAD. The diagnosis of PAD frequently occurs late in the process. The purpose of this study was to understand the relationship between mild or severe PAD and disability (health-related quality of life) and determine which factors affect that relationship. This study explored pain, mobility and activity alterations in response to PAD. Sociodemographic, chronic diseases and biological risk factors were also examined. A cross-sectional design was used to examine 4559 adults age 40 and over from the NHANES 2001-2004 data. An ankle- brachial index (ABI) measured PAD severity and the Center for Disease Control and Prevention Health-Related Quality of Life 4 question set measured physical, mental and activity disability. Comparisons of PAD levels: severe (ABI less than 0.7), mild (ABI 0.7- 0.9) and no disease showed that differences in pain, activity, mobility and risk factors become apparent when PAD is considered asymptomatic. Logistic regression showed physical disability was 1.7 times (95% CI 1.3, 2.2) more likely with mild PAD than no disease.
    [Show full text]